SUMMARY Serum phenobarbital, phenytoin and primidone levels were determined before, during and after addition of ethylphenacemide to the medication of 7 male patients, all with normal liver function and blood counts. During ethylphenacemide medication, a statistically significant increase in levels of phenobarbital and phenytoin in the serum was found. Thus therapeutic and toxic effects of ethylphenacemide may be well due to this secondary action. RÉSUMÉ Le taux sérique de phénobarbital, de phénytoïne et de primidone ont été mesures avant, pendant et aprés l'adjonction d'éthylphénacémide a leur thérapeutique chez 7 patients adultes ayant des fonctions hépatiques et une numération globulaire normales. Pendant la médication avec éthylphénacémide on a observé une augmentation significative du taux sérique de phénobarbital et de phénytoïne. II est done possible que les effets thérapeutiques et toxiques de l'ethylphénacémide soient dus en réalitéà cette action secondaire.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.